Research Project on Computer-Assisted Diabetes Risk Management Started

InterComponentWare AG (ICW)Optimal treatment of diabetes is very difficult to achieve. The obstacles to overcome are varied: expensive treatments, poor patient adherence to treatment plans, insufficient data, etc. With these challenges in mind, a new research project titled "Computerassisted Diabetes Risk Management (CDRM)" was put in place to examine how eHealth solutions can improve diabetes care.

The project is a collaboration among several organizations: the eHealth specialist InterComponentWare (ICW), Roche Diagnostics, telematics company GeTeG, the Philipps University Marburg, and the University Medical Center Groningen. The scientific project serves people with diabetes in the Rhine-Neckar region of Germany with a newly developed system consisting of a combination of software solutions and digital devices. By harnessing the power of technology, the project authors hope to improve quality of care to reduce long-term complications of diabetes and strengthen quality of life for people who suffer from the disease.

How does the new Diabetes Risk Management System work?
The Diabetes Risk Management System consists of various software solutions offered by ICW and Accu-Chek blood glucose measurement devices provided by Roche Diagnostics. The components of the risk management system automate data flow and documentation and thus facilitate diabetes management that conforms to current treatment guidelines.

During the course of the study, ICW will provide patients with the personal health record LifeSensor®. Roche Diagnostics will supply patients with blood glucose meters (Accu-Chek® Aviva and the information management system Accu-Chek® SmartPix) free of charge. On a regular basis, patients will measure their blood glucose values at home. Via Accu-Chek SmartPix they will be able to analyze easy-to-understand blood glucose graphs and statistics on their personal computers.

The Roche Diagnostics glucose meters can save up to 400 values. At the patient's next consultation, these data will be transferred to a physician's computer and uploaded to the CDM Diabetes Monitor, a software solution based on ICW's Care and Disease Manager application. The CDM Diabetes Monitor improves management of diabetes patients in the primary care study setting.

In addition to blood glucose data, the CDM Diabetes Monitor collects further information relevant for diabetes patients including basic parameters such as blood pressure, weight, waist and hip size. Moreover, laboratory blood test results are also collected. These data are then transferred via an integrated interface to Roche Diagnostics where it is processed into an Accu-Chek® Mellibase risk report. Based on the patient's individual health status, the risk report provides him or her with a 10-year risk prognosis of developing complications related to diabetes. The report also explains how this risk can be reduced by optimizing the patient's diabetes care. This information constitutes the basis for a decision-making process that focuses on the patient's unique health situation.

The Accu-Chek Mellibase report is made available to physicians via the CDM Diabetes Monitor. Likewise, the report will also be stored in patient's personal LifeSensor record.

Study design
The study is a prospective, randomized and controlled intervention study. In total 1,200 patients with type 2 diabetes will be recruited. These patients range in age between 38 and 68 years. Twenty-four primary care physicians and one specialist will also participate in the study. The research project is scheduled to be completed within 2 years. During the study period, patients will have at least four health check visits at six months intervals.

The concept for the CDRM research project was designed by the Department of Epidemiology at the University of Groningen, the Netherlands in cooperation with the Institute of Medical Sociology and Social Medicine at the Philipps University Marburg, Germany. For further information on the scientific evaluation, please visit the study's homepage: www.study-on-diabetes-management-systems.de

Related news articles:

About Accu-Chek
Accu-Chek is the world's leading diabetes care brand in the field of blood glucose self-management from Roche Diagnostics. Besides innovative systems for blood glucose self-control the company in cooperation with leading scientists develops under the brand Accu-Chek a wide brand portfolio of products and services to improve health and quality of life for people with diabetes. Furthermore, the company supports an extensive network of actors in the health care sector by setting up information and care services aiming at long-term optimization of quality of care.

About InterComponentWare
InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, Austria, Switzerland, USA, and Bulgaria. ICW's solutions connect the various protagonists in the health care sector and thus improve process-oriented communication and data integrity. This increases the quality of medical care. Its LifeSensor personal health record presents a perfect example, as it opens the way to health for every person. Networking solutions for hospitals and physicians from ICW Professional Suite facilitate the cross-sector communication of medical data. In addition, ICW provides technologies and services for national eHealth infrastructure projects. As part of the biT4health consortium, ICW has served as an important consultant for the introduction of the electronic health card in Germany. Furthermore, ICW is involved in the eCard project in Austria and has won the public tender for the pilot project to implement the Bulgarian electronic health card.

Most Popular Now

Siemens Healthineers Uses Artificial Int…

Siemens Healthineers introduces Ysio X.pree(1), the world's first intelligent X-ray system with integrated AI for optimizing the daily routine of image acquisition in radiography. To assist radiologists with the subsequent...

Digital Mental Health Interventions Have…

Treating anxiety and depression with digital mental health therapy has a significant and long-term benefit for recovery, new research amongst NHS service users suggests. The research was undertaken by SilverCloud...

FDA Permits Marketing of First Game-Base…

The U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD). The prescription-only...

HealthTunes Launches iOS App to Deliver …

HealthTunes has announceed the launch of the iOS App specifically created to help alleviate the mental health suffering of frontline healthcare workers. After months of fighting the pandemic, many frontline...

Philips Announces Collaboration with Ame…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has once again joined forces with the American Telemedicine Association (ATA) to help further the...

Roche Improves Speed and Accuracy of Non…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The...

Successful Debut for DMEA sparks

16 - 18 June 2020, Berlin, Germany. DMEA sparks opened, featuring a wide range of topics. Federal Minister of Health Jens Spahn kicked off events. In his interview he focused on...

Brazilian Scientists Develop COVID-19 Ac…

Researchers at São Paulo State University (UNESP) in Araçatuba, Brazil, have developed a computational tool that acts like a "COVID-19 accelerometer," plotting in real time the rate at which growth...

Wearable Injectors and Connected Devices…

7 - 8 October 2020, London, United Kingdom. The global wearable devices market size is expected to reach a value of $62.82 billion USD by 2025 with time dependent delivery, improved...

Siemens Healthineers Offers Flexible Tel…

With its teamplay myCare Companion software, the company is bringing a new and flexible telemedicine solution to the market that enables remote care for patients with chronic diseases. The teamplay...

Andrea Fiumicelli Appointed as a CEO of …

Dedalus Group, leader in Europe and one of the world's leading players in clinical and healthcare information systems supporting clinical professionals and healthcare facilities thanks to a wide portfolio of...

Oracle Unveils Clinical One Data Collect…

Electronic Data Capture (EDC) is no longer sufficient for today’s clinical trials, which are incorporating more virtual components and becoming more decentralized. While traditional EDC systems capture data from forms...